Search company, investor...


Founded Year



Series A | Alive

Total Raised


Last Raised

$17.3M | 3 yrs ago

About Genespire

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.

Headquarters Location



Missing: Genespire's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Genespire's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Genespire

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Genespire is included in 2 Expert Collections, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Genespire News

BI’s Fine becomes president of R&D at EvolveImmune

Jul 8, 2022

BI’s Fine becomes president of R&D at EvolveImmune Plus Sallah joins Genespire as CMO, and updates from Kinaset, Andera, Ariceum and more By Richard Guy, Biopharma Analyst and Gunjan Ohri, Data Content Analyst July 8, 2022 12:35 AM UTC Connecticut-based immuno-oncology play EvolveImmune Therapeutics Inc. hired Jay Fine as president of R&D. Fine joins from Boehringer Ingelheim GmbH, where he was SVP and global therapeutic area ... Access this Article

Genespire Frequently Asked Questions (FAQ)

  • When was Genespire founded?

    Genespire was founded in 2020.

  • Where is Genespire's headquarters?

    Genespire's headquarters is located at Milan.

  • What is Genespire's latest funding round?

    Genespire's latest funding round is Series A.

  • How much did Genespire raise?

    Genespire raised a total of $17.3M.

  • Who are the investors of Genespire?

    Investors of Genespire include Sofinnova Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.